AARON JASPER: Open Payments
NPI 1780132290 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 122 payments from 19 companies in 2025. Trend: 2023 $236 · 2024 $1,989 · 2025 $2,038
Food & beverage: $2,012Education: $26
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $543 |
| PFIZER INC. | 24 | $323 |
| Axsome Therapeutics, Inc. | 7 | $186 |
| Novo Nordisk Inc | 14 | $159 |
| Otsuka America Pharmaceutical, Inc. | 11 | $146 |
| Lilly USA, LLC | 10 | $139 |
| Esperion Therapeutics, Inc. | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
Products named: NURTEC ODT, VRAYLAR, Auvelity, UBRELVY, REXULTI, QULIPTA, MOUNJARO, NEXLETOL.
Industry payments across AL — which companies pay providers there.
